×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [11]
内容类型
期刊论文 [11]
发表日期
2019 [2]
2018 [4]
2017 [1]
2016 [2]
2015 [1]
2014 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain Metastases
期刊论文
2019, 卷号: 10, 期号: 9, 页码: 1985-1990
作者:
Wang, Chunyu
;
Lu, Xiaotong
;
Zhou, Zongmei
;
Wang, Jingbo
;
Hui, Zhouguang
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
EGFR mutation
brain metastases
radiation
tyrosine kinase inhibitors
Clinicopathologic characteristics and outcome of patients with different EGFR mutations
期刊论文
2019, 卷号: 15, 期号: 3, 页码: 166-171
作者:
Zhou, Shengyu
;
Hu, Xingsheng
;
Wang, Yan
;
Li, Junling
;
Zhou, Liqiang
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/03
EGFR-tyrosine kinase inhibitors
icotinib
nonsmall cell lung cancer
uncommon EGFR mutations
The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs
期刊论文
2018, 卷号: 97, 期号: 30, 页码: e11648
作者:
Zhang, Yuan
;
Feng, Yang-Chun
;
Zhu, Hong-Ge
;
Xiong, Ting-Chuan
;
Hou, Yan-Shen
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
epidermal growth factor receptor
lymphocyte-to-monocyte ratio
neutrophil-to-lymphocyte ratio
nonsmall cell lung cancer
tyrosine kinase inhibitors
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
期刊论文
2018, 卷号: 11, 页码: 6189-6196
作者:
Liang, Hongge
;
Liu, Xiaoyan
;
Wang, Mengzhao
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
epidermal growth factor receptor-tyrosine kinase inhibitors
immunotherapy
Combination TS-1 plus EGFR-tyrosine kinase inhibitors (TKIs) for the treatment of non-small cell lung cancer after progression on first-line or further EGFR-TKIs: A phase II, single-arm trial
期刊论文
2018, 卷号: 9, 期号: 6, 页码: 693-698
作者:
Yang, Lu
;
Yang, Sheng
;
Liu, Yutao
;
Li, Junling
;
Hu, Xingsheng
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Acquired resistance
EGFR-tyrosine kinase inhibitors
non-small cell lung cancer
phase II study
TS-1
First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients with EGFR-Mutant Metastatic NSCLC Receiving TKIs
期刊论文
2018, 卷号: 13, 期号: 10, 页码: S892-S892
作者:
Lu, X.
;
Wang, J.
;
Wang, C.
;
Bi, N.
;
Zhou, Z.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/03
Tyrosine kinase inhibitors
non-small cell lung cancer
Radical local therapy
EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs
期刊论文
2017, 卷号: 403, 页码: 186-194
作者:
Liang, Zhiyong
;
Cheng, Ying
;
Chen, Yuan
;
Hu, Yanping
;
Liu, Wei-Ping
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/04
EGFR T790M mutation
Tyrosine kinase inhibitors
NSCLC
Drug resistance
Evaluation of Three Small Molecular Drugs for Targeted Therapy to Treat Nonsmall Cell Lung Cancer
期刊论文
2016, 卷号: 129, 期号: 3, 页码: 332-340
作者:
Ni, Jun
;
Zhang, Li
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2020/01/04
Advanced Nonsmall Cell Lung Cancer
Epithelial Growth Factor Receptor
Optimal Selection
Tyrosine Kinase Inhibitors
Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
期刊论文
2016, 卷号: 34, 期号: 6, 页码: 258.e15-22
作者:
Song, Yan
;
Du, Chunxia
;
Zhang, Wen
;
Sun, Yongkun
;
Yang, Lin
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/04
Renal cell carcinoma
Kidney
Tyrosine kinase inhibitors
Prognosis
Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lung cancer
期刊论文
2015, 卷号: 11, 期号: 3, 页码: 385-397
作者:
Tan, Fenlai
;
Shi, Yuankai
;
Wang, Yinxiang
;
Ding, Lieming
;
Yuan, Xiaobin
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/13
EGF receptor tyrosine kinase inhibitors
icotinib
molecular targeted therapy
non-small-cell lung cancer
©版权所有 ©2017 CSpace - Powered by
CSpace